T. Rowe Price Associates’s Aemetis AMTX Stock Holding History
Bought
Maintained
Sold
Other funds holding AMTX
VCM
T. Rowe Price Associates's AMTX Position: Q1 2026 in Review
T. Rowe Price Associates increased its Aemetis (AMTX) stake by 65% in Q1 2026, buying an estimated $24.2K and bringing the position to 33,763 shares worth $108K. The position accounts for ﹤0.01% of the portfolio, ranked #2985.
T. Rowe Price Associates first reported a position in AMTX in Q3 2021 and has held it in 19 quarters since. The position peaked at $481K in Q1 2022. 78 funds tracked by Wall St. Rank hold AMTX as of Q1 2026.
- T. Rowe Price Associates held 33,763 shares of Aemetis worth $108K as of Q1 2026.
- T. Rowe Price Associates bought 13,300 Aemetis shares in Q1 2026, an estimated $24.2K.
- Aemetis made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #2985 holding.
- T. Rowe Price Associates first reported a position in Aemetis in Q3 2021 and has held it in 19 quarters since.
- T. Rowe Price Associates's Aemetis position peaked at $481K in Q1 2022.
- 78 funds tracked by Wall St. Rank held Aemetis as of Q1 2026.
Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.